CA-A Cancer Journal for Clinicians

Papers
(The H4-Index of CA-A Cancer Journal for Clinicians is 49. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-05-01 to 2025-05-01.)
ArticleCitations
Minority groups underrepresented in hematologic cancer trials13428
Evolution of community outreach and engagement at National Cancer Institute‐Designated Cancer Centers, an evolving journey11607
Antibody–drug conjugates: Smart chemotherapy delivery across tumor histologies7389
4510
Issue Information1816
Near majority of adults favor R ratings for films with smoking1650
Highlighting American Cancer Society‐funded research in CA: A Cancer Journal for Clinicians1421
Cancer care for transgender and gender‐diverse people: Practical, literature‐driven recommendations from the Multinational Association of Supportive Care in Cancer663
Cancer statistics 2024: All hands on deck447
Most patients with cancer are not undergoing germline genetic testing443
Breast cancer: The good, the bad, and an important call to effective risk reduction strategies413
Current treatment and future directions in the management of anal cancer334
Multicancer detection tests: What we know and what we don’t know277
More care needed for cancer caregivers263
262
Issue Information259
Underrepresentation of Hispanic women in science, technology, engineering, mathematics, and medicine258
Clinical practice guideline and expert consensus recommendations for rehabilitation among children with cancer: A systematic review223
Magnetic resonance linear accelerator technology and adaptive radiation therapy: An overview for clinicians169
Reduced‐volume radiotherapy versus conventional‐volume radiotherapy after induction chemotherapy in nasopharyngeal carcinoma: An open‐label, noninferiority, multicenter, randomized phase 3 trial167
Health insurance status and cancer stage at diagnosis and survival in the United States162
The evolving landscape of tissue‐agnostic therapies in precision oncology152
Multidisciplinary management in the treatment of intrahepatic cholangiocarcinoma148
Does distance deter male fertility preservation?143
Medicaid expansion increases survival for patients with cancer138
Lung cancer screening guidelines: Smoking matters, not quitting129
Study identifies risk factors that may lead to secondary cancers126
Overlooked barriers to implementation of geriatric assessment123
Interventional gastroenterology in oncology120
The contemporary management of cancers of the sinonasal tract in adults119
Cancer survivors at greater risk for bone fractures late in life107
From medical student to Editor: A note of thanks98
Issue Information94
Screening for lung cancer85
Bilateral mastectomy may not reduce mortality risk79
Issue Information79
Interpreting and integrating genomic tests results in clinical cancer care: Overview and practical guidance68
Issue Information67
Breast Cancer Statistics, 202267
Clinical management of metastatic colorectal cancer in the era of precision medicine64
Prevention of device‐related infections in patients with cancer: Current practice and future horizons64
Cancer treatment and survivorship statistics, 202260
American Cancer Society nutrition and physical activity guideline for cancer survivors58
Better communication is key for quality‐of‐life improvement in low‐income and minority patients56
53
Issue Information52
A pan‐tumor review of the role of poly(adenosine diphosphate ribose) polymerase inhibitors51
Cancer misinformation on social media50
49
0.044821977615356